Impact and challenges of enactment for advanced regenerative medicine in South Korea.

Kim, Dong-Sook; Bae, SeungJin

Kim, Dong-Sook; Bae, SeungJin.

Affiliation

Kim DS; Department of Research, Health Insurance Review and Assessment Service, Wonju, South Korea.
Bae S; College of Pharmacy, Ewha Womans University, Seoul, South Korea.

Front Bioeng Biotechnol ; 10: 972865, 2022.

Article in En | MEDLINE | ID: mdl-36312539

Key words

South Korea; biological products; enactment; regenerative medicine; safety

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597240
https://dx.doi.org/10.3389/fbioe.2022.972865

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Bioeng Biotechnol Year: 2022 Document type: Article

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597240
https://dx.doi.org/10.3389/fbioe.2022.972865

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Bioeng Biotechnol Year: 2022 Document type: Article